Mei He

Mei He, Ph.D.

Assistant Professor

Department: Pharmaceutics
Business Phone: (352) 273-9847
Business Email:

About Mei He

Mei He, Ph.D. is a tenure-track assistant professor in the Department of Pharmaceutics at the University of Florida in Gainesville. She received her PhD degree from the University of Alberta and postdoctoral training from the University of California, Berkeley from 2008-2012. Dr. He is also the founder of Clara Biotech Inc. and the founder committee for the MidWest 3D technology society. Dr. He received the NIH Maximizing Investigator’s Research Award (MIRA ESI), as well as the LOC Emerging Investigators in 2019, and Outstanding LOC Reviewers in 2018 by the Royal Society of Chemistry. Dr. He also serves the Editorial Board Member for journals Lab on Chip (IF 6.91) and Pharmaceutics (IF 4.8). He publications received Top 100 Read Articles in 2019 from Nature Publsihing group, as well as the SLAS Technology Readers Choice Award in 2018.


NIH Maximizing Investigator's Research Award for Early Stage Investigators
2019 · National Institutes of Health
LOC Emerging Investigator
2019 · Royal Society of Chemistry
Reader Choice Award
2018 · Society for Laboratory Automation and Screening
Outstanding Reviewer for Lab on Chip
2018 · Royal Society of Chemistry
New Faculty Award
2017 · Kansas State University
Travel Award for NIH-IEEE Strategic Conference
2016 · Johnson Cancer Research Center
Ingenuity Central Kansas Innovator
2016 · Kansas State University
NSF CAREER Workshop Travel Award
2014 · National Science Foundation
Auxiliary Award
2013 · University of Kansas Medical Center
CASSS Travel Award for the 26th International Symposium on MicroScale Bioseparations
2011 · CASSS
NSF ADVANCE Future Faculty Workshop Travel Award
2011 · National Science Foundation
Final list, California Institute for Quantitative Bioscience (QB3) Distinguished Fellow The University of California, Berkeley, USA
2008 · California Institute for Quantitative Bioscience
Mary Louise Imrie Graduate Student Award
2007 · University of Alberta, Canada

Research Profile

Dr. He’s research focuses on precise definition and control of immunity at the molecular level to tissue level, via extracellular vesicles and exosomes -mediated delivery and biological programming strategies, which can be employed in advancing cancer immunotherapy, regenerative medicine, and precision therapeutics. The long-standing interest is to understand immunity communication and delivery for translating into novel therapeutics and treatments against cancers, autoimmune diseases, and infectious diseases which immune responses are the central player.

Areas of Interest
  • 3D Printing and Biomaterials
  • Cancer Immunotherapy
  • Extracellular Vesicles and Exosomes for Biological Programming and Nanodelivery
  • Microfluidic organ on chip
  • Regenerative and Precision Therapeutics



Aug 2020 ACTIVE
3D biomimetic lymph node engineered extracellular vesicles for understanding the heterogeneity of adaptive immunity
NATL INST OF HLTH NIGMS · Principal Investigator


Postdoc, Bioengineering
2008-2011 · University of California-Berkeley, USA,
Ph.D., Chemistry
2004-2008 · University of Alberta, Canada,
M.S., Pharmaceutical Chemistry
2000-2003 · Chongqing University, China,
B.S., Chemical Engineering, with Honors
1996-2000 · Chongqing University, China,

Contact Details

(352) 273-9847